financetom
Business
financetom
/
Business
/
Update: Wix.com Shares Rise After Q2 Beat
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Wix.com Shares Rise After Q2 Beat
Aug 6, 2025 11:57 AM

02:29 PM EDT, 08/06/2025 (MT Newswires) -- (Updates with stock price movement in the headline and the first paragraph.)

Wix.com ( WIX ) shares were up 3.7% in recent Wednesday trading after the company posted better-than-expected Q2 financial results.

The company reported Q2 non-GAAP earnings Wednesday of $2.28 per diluted share, up from $1.67 a year earlier.

Analysts polled by FactSet expected $1.75.

Revenue for the quarter ended June 30 was $489.9 million, compared with $435.7 million a year earlier.

Analysts surveyed by FactSet expected $487.3 million.

For Q3, the company expects total revenue to be $498 million to $504 million. Analysts surveyed by FactSet expect $502.5 million.

The company raised the lower end of its 2025 revenue guidance to $1.98 billion to $2 billion, compared with the prior outlook of $1.97 billion to $2 billion. Analysts surveyed by FactSet expect $1.99 billion.

Price: 132.85, Change: +4.76, Percent Change: +3.72

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Organon Says US FDA Accepts Biologic License Application for Proposed Denosumab Biosimilar HLX14
Organon Says US FDA Accepts Biologic License Application for Proposed Denosumab Biosimilar HLX14
Oct 30, 2024
10:57 AM EDT, 10/30/2024 (MT Newswires) -- Organon (OGN) and Shanghai Henlius Biotech said Wednesday that the US Food and Drug Administration has accepted the biologic license application for HLX14, an investigational biosimilar of denosumab. Denosumab is approved in several countries for different indications including the treatment of osteoporosis in postmenopausal women, the companies said. Organon secured the exclusive commercialization...
Sector Update: Consumer Stocks Mixed Premarket Wednesday
Sector Update: Consumer Stocks Mixed Premarket Wednesday
Oct 30, 2024
09:18 AM EDT, 10/30/2024 (MT Newswires) -- Consumer stocks were mixed premarket Wednesday, with The Consumer Staples Select Sector SPDR Fund ( XLP ) slightly lower and The Consumer Discretionary Select Sector SPDR Fund ( XLY ) up 0.3%. Brinker International ( EAT ) shares were up over 7% after the company reported higher fiscal Q1 adjusted earnings and revenue...
Bunge Beats On Q3 Earnings, Agribusiness Weighs On Growth Amid Global Margin Pressure
Bunge Beats On Q3 Earnings, Agribusiness Weighs On Growth Amid Global Margin Pressure
Oct 30, 2024
Bunge Limited reports strong Q3 earnings of $2.29 per share, exceeding expectations. Results declined from the prior year due to the current global margin environment.Bunge Limited reported third-quarter adjusted earnings per share of $2.29, beating the street view of $2.14. Quarterly sales of $12.908 billion outpaced the analyst consensus estimate of $12.774 billion. Bunge Global ( BG ) said it...
bioAffinity Technologies Secures Japanese Patent for Lung Cancer Diagnostic Method
bioAffinity Technologies Secures Japanese Patent for Lung Cancer Diagnostic Method
Oct 30, 2024
10:42 AM EDT, 10/30/2024 (MT Newswires) -- bioAffinity Technologies (BIAF) said Wednesday it received a Japanese patent for its CyPath Lung diagnostic test method, which predicts lung cancer risk. The patent expands bioAffinity's portfolio to 17 granted patents, the company said. Shares of bioAffinity rose 2.7% in recent trading. Price: 1.34, Change: +0.03, Percent Change: +2.69 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved